search
Back to results

Fiber-enriched Croissant Consumption and Effects on Metabolic Status, Appetite and Gut Microbiota (CROMA)

Primary Purpose

Healthy, Overweight and Obesity

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Fiber Croissant (FIBCRO) Group
Control Croissant (CONCRO) Group
Sponsored by
Federico II University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Healthy

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy subjects;
  • men and women;
  • age 18-50 years;
  • 20 kg/m2 ≤ BMI ≤ 35 kg/m2;
  • habitual daily breakfast consumption (≥ 250kcal/day);
  • habitual diet characterized by absence of any food supplements and alternative medication, probiotics and prebiotics, whole grain and/or fiber enriched foods;
  • intake of fruit/vegetables < 3 servings/day;
  • low level of physical activity;
  • signed written informed consent.

Exclusion Criteria:

  • food allergies and intolerances and celiac disease;
  • gastrointestinal diseases;
  • relevant diseases;
  • pregnant or breastfeeding;
  • previous abdominal surgery;
  • hypertriglyceridemia (Triglycerides > 200 mg/dL);
  • hypercholesterolemia (Total cholesterol > 200 mg/dL);
  • hyperglycaemia (glycaemia ≥ 110 mg/dL);
  • hypertension (arterial blood pressure ≥140/90 mm Hg);
  • weight loss ≥ 3 kg within 2 months before the study;
  • antibiotics treatment within 3 months before the study;
  • any medication (different from antibiotics) at the enrollment and within 2 months before the study;
  • habitual diet characterized by high fruit and vegetables intakes (>3 portion/die);
  • high level of physical activity;
  • alcohol consumption ≥ 3 alcohol units per day;
  • simultaneous participation in other trial.

Sites / Locations

  • Department of Agricultural Sciences, Federico II University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Fiber Croissant (FIBCRO) Group

Control Croissant (CONCRO) Group

Arm Description

Daily consumption at breakfast for 2 weeks of a fiber-enriched croissant

Daily consumption at breakfast for 2 weeks of a control croissant

Outcomes

Primary Outcome Measures

Variation of daily energy intakes
Calculation of total daily energy intakes based on 7 days food records

Secondary Outcome Measures

Changes in fasting plasma inflammatory markers
Measure of plasma C-reactive protein (mmol/L)
Changes in fasting plasma lipids
Measure of plasma concentrations (mg/dL) of Total-, LDL-, and HDL-Cholesterol, as well as Triglycerides
Changes in fasting blood glucose
Measure of blood glucose concentrations (mg/dL)
Variation of serum Insulin hormone concentration
Measure of serum Insulin concentrations (mg/dL)
Variation of plasma endocannabinoids and N-acyl-ethanolamines concentration
Measure of plasma endocannabinoids and N-acyl-ethanolamines concentrations (mg/dL)
Variation of serum dipeptidyl-dipeptidase-IV activity
Measure of serum dipeptidyl-dipeptidase-IV (U/L) activity
Variation of urinary excretion levels of polyphenols
Measure of polyphenols concentration in urine by mean of liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS)
Variation of urinary excretion levels of urolithins
Measure of urolithins concentration in urine by mean of LC/MS/MS
Changes in stool consistency
Measure of consistency of feces by mean of King's stool chart filled out by subjects. The chart comprises four categories of stool consistency: hard and formed, soft and formed, loose and unformed, liquid.
Changes in stool weight
Measure of stool weight by mean of King's stool chart filled out by subjects. The chart comprises three categories of stool weight : <100 g, 100-200 g, >200 g.
Changes in stool frequency
Measure of frequency of feces by mean of King's stool chart filled out by subjects. Fecal frequency is incorporated by recording the code of each feces passed over a 24 hour period.
Changes in gastrointestinal functionality
Calculation of daily fecal score from summation of all scores for stool consistency, weight and frequency obtained from King's stool chart filled out by subjects. Scores are weighted such that an increase in fecal frequency alone results in a higher score than a change in fecal consistency alone, which in turn results in a higher score than an increase in fecal weight alone. Diarrhea is classified by a daily fecal score of 15 or more.
Changes in faecal microbiome
The composition of faecal microbiome will be determined by high throughput sequencing of the ribosomal ribonucleic acid 16S (16S rRNA) gene. The massive number of sequences obtained will be analyzed by using state of the art bioinformatics tools and the presence and relative abundance of the microbial species occurring in each sample will be determined.
Changes in body weight
Measure of body weight in fasting subjects
Changes in body mass index
Calculation of body mass index by using the formula weight in kilograms divided by height in meters squared.
Changes in waist circumference
Measure of waist circumference at the midpoint between the lower margin of the least palpable rib and the top of the iliac crest.
Changes in hip circumference
Measure of hip circumference around the widest portion of the buttocks.
Changes in blood pressure
Measure of systolic pressure and diastolic pressure in millimetres of mercury (mmHg) by using a digital sphygmomanometer
Changes in body composition
Body composition is determined by conventional bioelectrical impedance analysis with a single-frequency 50 kilohertz (kHz) bioelectrical impedance analyzer in the postabsorptive state (fasting subjects) and after being in the supine position for 20 min. Body composition data will be calculated from bioelectrical measurements and anthropometric data by using validated predictive equations.
Variation of hunger feeling scores
Measures of hunger sensation over the day reported by subjects by using hunger Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating hunger.
Variation of fullness feeling scores
Measure of fullness sensation over the day reported by subjects by using fullness Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating fullness.
Variation of satiety feeling scores
Measure of satiety sensation over the day reported by subjects by using satiety Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating satiety.

Full Information

First Posted
August 5, 2021
Last Updated
January 11, 2023
Sponsor
Federico II University
search

1. Study Identification

Unique Protocol Identification Number
NCT04999280
Brief Title
Fiber-enriched Croissant Consumption and Effects on Metabolic Status, Appetite and Gut Microbiota
Acronym
CROMA
Official Title
Effect of Daily Consumption of a Fiber-enriched Croissant on Metabolic Status, Dietary Habits and Gut Microbiota in Healthy Subjects (CROMA)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
June 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federico II University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this study is to evaluate the effect of a daily consumption for 2 weeks of a sourdough croissant enriched with dietary fibers vs a control sourdough croissant with no fiber added on daily energy intakes, fasting metabolic parameters, inflammatory status, blood pressure, anthropometric measures, body composition, appetite sensations, gastrointestinal functionality and gut microbiota composition.
Detailed Description
Associations between human health, diet and gut microbiota composition and functionality have been widely highlighted by the scientific literature in this field. Evidence shows that population adopting a Western dietary model, with a reduced intake of dietary fiber, undergo an adaptation of the gut microbiota characterized by the loss of some bacterial species and a general reduction in microbial biodiversity. The national guidelines for a healthy diet suggest to include daily fruit, vegetables, whole grains and legumes (the main sources of fiber in the diet) in the habitual diet to reduce the risk of diseases and to improve health. However, the compliance with these nutritional recommendations is generally low among individuals. Therefore, the commercial availability of dietary fiber-enriched products could be advantageous. Breakfast is an important meal that should provide at least 20% of the daily calories with an adequate supply of all nutrients. Having fiber-enriched foods for breakfast could bring numerous nutritional benefits and if they are made with sourdough may be even better. Indeed, sourdough leavened baked products provide compounds with potential prebiotic activity, reduce the glucose and insulin response, increase satiety and reduce gastro-intestinal disorders upon consumption. The hypothesis is that the combination of sourdough and dietary fiber in baked products could further ameliorate glucose metabolism in consumers compared to sourdough products. The aim of this study is to evaluate the effects of a daily consumption at breakfast for 2 weeks of a sourdough croissant enriched with dietary fibers from 10 different sources vs a sourdough croissant with no fiber added (control) on daily energy intakes, metabolic and inflammatory status, appetite feelings, body weight, body mass index (BMI), waist and hip circumferences, body composition, blood pressure, gut microbiota composition and gastrointestinal functionality in healthy subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Overweight and Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fiber Croissant (FIBCRO) Group
Arm Type
Experimental
Arm Description
Daily consumption at breakfast for 2 weeks of a fiber-enriched croissant
Arm Title
Control Croissant (CONCRO) Group
Arm Type
Active Comparator
Arm Description
Daily consumption at breakfast for 2 weeks of a control croissant
Intervention Type
Other
Intervention Name(s)
Fiber Croissant (FIBCRO) Group
Other Intervention Name(s)
Fiber-enriched Croissant
Intervention Description
Subjects will consume for 2 weeks at breakfast a fiber-enriched sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.
Intervention Type
Other
Intervention Name(s)
Control Croissant (CONCRO) Group
Other Intervention Name(s)
Control Croissant
Intervention Description
Subjects will consume for 2 weeks at breakfast a sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.
Primary Outcome Measure Information:
Title
Variation of daily energy intakes
Description
Calculation of total daily energy intakes based on 7 days food records
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Changes in fasting plasma inflammatory markers
Description
Measure of plasma C-reactive protein (mmol/L)
Time Frame
2 weeks
Title
Changes in fasting plasma lipids
Description
Measure of plasma concentrations (mg/dL) of Total-, LDL-, and HDL-Cholesterol, as well as Triglycerides
Time Frame
2 weeks
Title
Changes in fasting blood glucose
Description
Measure of blood glucose concentrations (mg/dL)
Time Frame
2 weeks
Title
Variation of serum Insulin hormone concentration
Description
Measure of serum Insulin concentrations (mg/dL)
Time Frame
2 weeks
Title
Variation of plasma endocannabinoids and N-acyl-ethanolamines concentration
Description
Measure of plasma endocannabinoids and N-acyl-ethanolamines concentrations (mg/dL)
Time Frame
2 weeks
Title
Variation of serum dipeptidyl-dipeptidase-IV activity
Description
Measure of serum dipeptidyl-dipeptidase-IV (U/L) activity
Time Frame
2 weeks
Title
Variation of urinary excretion levels of polyphenols
Description
Measure of polyphenols concentration in urine by mean of liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS)
Time Frame
2 weeks
Title
Variation of urinary excretion levels of urolithins
Description
Measure of urolithins concentration in urine by mean of LC/MS/MS
Time Frame
2 weeks
Title
Changes in stool consistency
Description
Measure of consistency of feces by mean of King's stool chart filled out by subjects. The chart comprises four categories of stool consistency: hard and formed, soft and formed, loose and unformed, liquid.
Time Frame
2 weeks
Title
Changes in stool weight
Description
Measure of stool weight by mean of King's stool chart filled out by subjects. The chart comprises three categories of stool weight : <100 g, 100-200 g, >200 g.
Time Frame
2 weeks
Title
Changes in stool frequency
Description
Measure of frequency of feces by mean of King's stool chart filled out by subjects. Fecal frequency is incorporated by recording the code of each feces passed over a 24 hour period.
Time Frame
2 weeks
Title
Changes in gastrointestinal functionality
Description
Calculation of daily fecal score from summation of all scores for stool consistency, weight and frequency obtained from King's stool chart filled out by subjects. Scores are weighted such that an increase in fecal frequency alone results in a higher score than a change in fecal consistency alone, which in turn results in a higher score than an increase in fecal weight alone. Diarrhea is classified by a daily fecal score of 15 or more.
Time Frame
2 weeks
Title
Changes in faecal microbiome
Description
The composition of faecal microbiome will be determined by high throughput sequencing of the ribosomal ribonucleic acid 16S (16S rRNA) gene. The massive number of sequences obtained will be analyzed by using state of the art bioinformatics tools and the presence and relative abundance of the microbial species occurring in each sample will be determined.
Time Frame
2 weeks
Title
Changes in body weight
Description
Measure of body weight in fasting subjects
Time Frame
2 weeks
Title
Changes in body mass index
Description
Calculation of body mass index by using the formula weight in kilograms divided by height in meters squared.
Time Frame
2 weeks
Title
Changes in waist circumference
Description
Measure of waist circumference at the midpoint between the lower margin of the least palpable rib and the top of the iliac crest.
Time Frame
2 weeks
Title
Changes in hip circumference
Description
Measure of hip circumference around the widest portion of the buttocks.
Time Frame
2 weeks
Title
Changes in blood pressure
Description
Measure of systolic pressure and diastolic pressure in millimetres of mercury (mmHg) by using a digital sphygmomanometer
Time Frame
2 weeks
Title
Changes in body composition
Description
Body composition is determined by conventional bioelectrical impedance analysis with a single-frequency 50 kilohertz (kHz) bioelectrical impedance analyzer in the postabsorptive state (fasting subjects) and after being in the supine position for 20 min. Body composition data will be calculated from bioelectrical measurements and anthropometric data by using validated predictive equations.
Time Frame
2 weeks
Title
Variation of hunger feeling scores
Description
Measures of hunger sensation over the day reported by subjects by using hunger Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating hunger.
Time Frame
2 weeks
Title
Variation of fullness feeling scores
Description
Measure of fullness sensation over the day reported by subjects by using fullness Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating fullness.
Time Frame
2 weeks
Title
Variation of satiety feeling scores
Description
Measure of satiety sensation over the day reported by subjects by using satiety Visual Analogue Scales (VAS) 0-10 centimeters (where 0 corresponds to the lowest and 10 to the highest feeling the individual could perceive). Changes in these scores may reflect potential effects of dietary intervention in modulating satiety.
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy subjects; men and women; age 18-50 years; 20 kg/m2 ≤ BMI ≤ 35 kg/m2; habitual daily breakfast consumption (≥ 250kcal/day); habitual diet characterized by absence of any food supplements and alternative medication, probiotics and prebiotics, whole grain and/or fiber enriched foods; intake of fruit/vegetables < 3 servings/day; low level of physical activity; signed written informed consent. Exclusion Criteria: food allergies and intolerances and celiac disease; gastrointestinal diseases; relevant diseases; pregnant or breastfeeding; previous abdominal surgery; hypertriglyceridemia (Triglycerides > 200 mg/dL); hypercholesterolemia (Total cholesterol > 200 mg/dL); hyperglycaemia (glycaemia ≥ 110 mg/dL); hypertension (arterial blood pressure ≥140/90 mm Hg); weight loss ≥ 3 kg within 2 months before the study; antibiotics treatment within 3 months before the study; any medication (different from antibiotics) at the enrollment and within 2 months before the study; habitual diet characterized by high fruit and vegetables intakes (>3 portion/die); high level of physical activity; alcohol consumption ≥ 3 alcohol units per day; simultaneous participation in other trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paola Vitaglione, Professor
Organizational Affiliation
Department of Agricultural Sciences, Federico II University
Official's Role
Study Director
Facility Information:
Facility Name
Department of Agricultural Sciences, Federico II University
City
Portici
ZIP/Postal Code
80055
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Fiber-enriched Croissant Consumption and Effects on Metabolic Status, Appetite and Gut Microbiota

We'll reach out to this number within 24 hrs